Sartorius Appoints Senior Vice President
News Oct 25, 2012
Sartorius Stedim Biotech has appointed its biopharmaceutical expert Stefan Schlack as Senior Vice President of Marketing.
In his new position, Schlack, who is an experienced Sartorius employee, will assume responsibility for all marketing and product management activities.
Stefan Schlack holds a university degree in business management and has been working for Sartorius since 1996.
After completing vocational training in industrial business management at Sartorius, he studied business economics and management in Cologne, Germany, and worked in field sales in the Sartorius laboratory business unit during his studies.
After earning his university degree, Schlack relocated to the USA, where he worked as a key account manager, supporting pharmaceutical customers and handling OEM business.
Upon his return to Sartorius headquarters in Goettingen in 2006, he was assigned responsibility for global key account management, covering international pharmaceutical companies.
Since 2008, Stefan Schlack has been in charge of key account management as Vice President.
Evolution Threatens Efficient Bioproduction Scale-UpNews
The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.
Sequencing Shows How Evolution Can Undermine Bioprocess CommercializationNews
Rapid evolution can suppress the effect of pro-production genes in biochemical processes.READ MORE
Lonza Expands Encapsulation and HPAPI Capabilities in North AmericaNews
Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.READ MORE
Comments | 0 ADD COMMENT
World Advanced Therapies & Regenerative Medicine Congress
May 16 - May 18, 2018